Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)
South Korea
· Delayed Price · Currency is KRW 10,720
+60 (0.56%)
Jan 21, 2025, 9:00 AM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 246.49 billion as of January 22, 2025. Its market cap has decreased by -51.93% in one year.
Market Cap
246.49B
Enterprise Value
199.64B
Revenue
69.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
10,720.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 246.49B, an increase of 53.82%. That is a compound annual growth rate of 10.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 246.49B | 2.78% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 355.59T |
| SK hynix | 150.21T |
| LG Energy Solution | 82.95T |
| Samsung Biologics Co.,Ltd. | 71.25T |
| Hyundai Motor Company | 45.49T |
| Kia Corporation | 39.35T |
| Celltrion | 38.12T |
| KB Financial Group | 33.29T |